Data on interferon-alpha (IFNα) efficacy in MPN patients further supports the theory of immune suppression: IFNα is an immunostimulatory drug capable of inducing long-lasting hematological and molecular remission in these patients (17, 18). The gene discussed is IFNA1; the disease is myeloproliferative neoplasm.